联系客服

002198 深市 嘉应制药


首页 公告 嘉应制药:2023年半年度财务报告

嘉应制药:2023年半年度财务报告

公告日期:2023-08-26

嘉应制药:2023年半年度财务报告 PDF查看PDF原文
(未经审计)


                                                      页码

1. 合并资产负债表                                    2-3

2. 合并利润表                                        4

3. 合并现金流量表                                    5

4. 合并股东权益变动表                                6-7

5. 母公司资产负债表                                  8-9

6. 母公司利润表                                      10

7. 母公司现金流表                                    11

8. 母公司股东权益变动表                              12-13

9. 财务报表附注                                      14-72


  货币资金                          六、1        213,164,105.81        183,858,033.90

  交易性金融资产                    六、2          60,000,000.00          50,260,821.92

  衍生金融资产

  应收票据                          六、3          17,248,575.80          40,005,962.35

  应收账款                          六、4          132,672,777.90        146,026,800.41

  应收款项融资                      六、5          14,270,117.92          38,579,332.01

  预付款项                          六、6          23,319,912.49          12,884,433.77

  其他应收款                        六、7            1,604,315.73          3,120,661.20

  存货                              六、8          80,993,861.26          82,284,816.35

  合同资产

  持有待售资产

  一年内到期的非流动资产

  其他流动资产                      六、9            2,251,880.48            411,647.83

  债权投资

  其他债权投资

  长期应收款

  长期股权投资                      六、10          26,607,028.34          29,378,955.16

  其他权益工具投资

  其他非流动金融资产

  投资性房地产

  固定资产                          六、11        198,245,437.29        203,702,731.27

  在建工程

  生产性生物资产

  油气资产

  使用权资产

  无形资产                          六、12          49,422,220.81          52,374,605.71

  开发支出

  商誉                              六、13

  长期待摊费用

  其他非流动资产                    六、15                                  1,547,873.00

(后附财务报表附注是本财务报表的组成部分)


  短期借款                            六、16

  交易性金融负债

  衍生金融负债

  应付票据

  应付账款                            六、17          9,683,018.04          18,975,313.81

  预收款项                            六、18            93,577.97            131,009.17

  合同负债                            六、19          2,226,986.59          10,985,628.58

  应付职工薪酬                        六、20          3,585,816.40          6,062,208.57

  应交税费                            六、21          7,744,880.55          17,212,023.51

  其他应付款                          六、22        12,149,586.35          22,378,799.53

  持有待售负债

  一年内到期的非流动负债

  其他流动负债                        六、23          6,160,119.65          7,202,143.58

  长期借款

  应付债券

  其中:优先股

        永续债

  租赁负债

  长期应付款

  长期应付职工薪酬

  预计负债

  递延收益                            六、24            476,223.91            539,100.25

  递延所得税负债                      六、14        34,746,735.76          34,746,735.76

  其他非流动负债

  股本                                六、25        507,509,848.00        507,509,848.00

  其他权益工具

  其中:优先股

        永续债

  资本公积                            六、26        121,859,095.39        123,406,532.58

  减:库存股

  其他综合收益

  专项储备

  盈余公积                            六、27        27,223,004.60          27,223,004.60

  未分配利润                          六、28        88,527,170.67          70,278,629.32

(后附财务报表附注是本财务报表的组成部分)


                                                          六、29

      减:营业成本                                      六、29    85,687,599.52    73,452,171.18

          税金及附加                                    六、30      4,387,019.18      4,480,224.60

          销售费用                                      六、31    123,519,809.85    130,960,115.85

          管理费用                                      六、32    21,573,876.69    23,878,521.05

          研发费用                                      六、33      3,451,304.73      3,318,011.92

          财务费用                                      六、34      -975,825.46    -1,366,846.52

          其中:利息费用                                                                  454,167.84

                利息收入                                              985,464.32      1,842,782.73

      加:其他收益                                      六、35      1,419,014.30        91,215.69

          投资收益                                      六、36        146,764.25        69,700.44

          其中:对联营企业和合营企业的投资收益                    -1,224,489.63        69,700.44

                以摊余成本计量的金融资产终止确认收益

          净敞口套期收益 (损失以“-”号填列)

          公允价值变动收益 (损失以“-”号填列)        六、37

          信用减值损失 (损失以“-”号填列)            六、38        563,820.10      -454,264.19

          资产减值损失 (损失以“-”号填列)            六、39      -435,980.55

                                                          六、40                            -5,371.29

      加:营业外收入                                    六、41        65,612.85            94.31

      减:营业外支出                                    六、42        665,686.33        386,066.34

                                  列)

      减:所得税费用                                    六、43      2,615,889.34      2,849,329.60

( 一) 按经营持续性分类:

1、持续经营净利润 (净亏损以“- ”号填列)                            18,248,541.35      8,594,745
[点击查看PDF原文]